Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
- DOI
- 10.1073/pnas.2112712119
- Published
- 2022-02-25
- Container
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1073/pnas.2112712119,
title = {Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2},
author = {Ranjan K. Singh and Ahmed Soliman and Giambattista Guaitoli and Eliza Störmer and Felix von Zweydorf and Thomas Dal Maso and Asmaa Oun and Laura Van Rillaer and Sven H. Schmidt and Deep Chatterjee and Joshua A. David and Els Pardon and Thomas U. Schwartz and Stefan Knapp and Eileen J. Kennedy and Jan Steyaert and Friedrich W. Herberg and Arjan Kortholt and Christian Johannes Gloeckner and Wim Versées},
year = {2022},
journal = {Proceedings of the National Academy of Sciences},
doi = {10.1073/pnas.2112712119},
url = {https://doi.org/10.1073/pnas.2112712119}
}RIS
TY - JOUR TI - Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2 AU - Ranjan K. Singh AU - Ahmed Soliman AU - Giambattista Guaitoli AU - Eliza Störmer AU - Felix von Zweydorf AU - Thomas Dal Maso AU - Asmaa Oun AU - Laura Van Rillaer AU - Sven H. Schmidt AU - Deep Chatterjee AU - Joshua A. David AU - Els Pardon AU - Thomas U. Schwartz AU - Stefan Knapp AU - Eileen J. Kennedy AU - Jan Steyaert AU - Friedrich W. Herberg AU - Arjan Kortholt AU - Christian Johannes Gloeckner AU - Wim Versées PY - 2022 JO - Proceedings of the National Academy of Sciences DO - 10.1073/pnas.2112712119 UR - https://doi.org/10.1073/pnas.2112712119 ER -
APA
Singh, R. K., Soliman, A., Guaitoli, G., Störmer, E., Zweydorf, F. V., Maso, T. D., Oun, A., Rillaer, L. V., Schmidt, S. H., Chatterjee, D., David, J. A., Pardon, E., Schwartz, T. U., Knapp, S., Kennedy, E. J., Steyaert, J., Herberg, F. W., Kortholt, A., Gloeckner, C. J., & Versées, W. (2022). Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2112712119
Source records
- crossref · retrieved 2026-09-27T10:47:35.004Z